Carolyn Dzierba
About Carolyn Dzierba
Carolyn Dzierba is a Director at Bristol Myers Squibb in Cambridge, Massachusetts, with over 15 years of experience in the pharmaceutical industry and a strong academic background in Chemistry.
Current Role at Bristol Myers Squibb
Carolyn Dzierba is currently working at Bristol Myers Squibb in Cambridge, Massachusetts. She serves in multiple significant roles within the company, including Director, Associate Director, and Senior Principal Scientist. These positions highlight her extensive expertise and leadership within the pharmaceutical industry.
Career at Bristol Myers Squibb
Carolyn Dzierba has been with Bristol Myers Squibb for over 15 years, holding a variety of roles. She began her tenure as a Senior Research Investigator II from 2001 to 2008, later advancing to Principal Scientist from 2008 to 2014 in Wallingford, Connecticut. Currently, she holds senior positions including Director, Associate Director, and Senior Principal Scientist in Cambridge, Massachusetts.
Previous Experience at DuPont Pharmaceuticals
Before joining Bristol Myers Squibb, Carolyn Dzierba worked at DuPont Pharmaceuticals as a Senior Research Investigator from 1999 to 2001. This role marked the beginning of her career in the pharmaceutical industry, laying the foundation for her subsequent roles in research and development.
Educational Background in Chemistry
Carolyn Dzierba has a robust academic background in Chemistry. She earned her B.S. from Indiana University Bloomington from 1988 to 1992. She then pursued a Ph.D. in Chemistry at UC Irvine, completing her studies from 1992 to 1997. Following this, she was a Postdoctoral Fellow at Boston College from 1997 to 1999, further solidifying her expertise in the field.
Expertise in Pharmaceutical Research and Development
With extensive experience in the pharmaceutical industry, Carolyn Dzierba has demonstrated expertise in various research and development roles. Her career trajectory includes critical research positions at DuPont Pharmaceuticals and long-term contributions at Bristol Myers Squibb, where she has been instrumental in multiple capacities over more than 15 years.